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To the Editor: A measles 
epidemic is currently occurring in 
several countries in Europe (1,2). 
Although most cases concern 
unvaccinated children and young 
adults, health care professionals 
(HCPs) are also affected. Cases occur 
mostly in unvaccinated persons, but 
also in those who have received a 
single dose of vaccine.
In France, the measles vaccine 
was introduced in the childhood-
immunization schedule in 1983. 
Current guidelines recommend 2 
doses: one at 12 months of age and the 
second between 13 and 24 months of 
age. For persons born after 1992, one 
catch-up dose is recommended (3). 
Coverage by >1 dose, by the age of 2 
years, remained at 83%–87% during 
1997–2005. The latest fi gures show a 
slight increase to 90% in 2007 (4).
The risk for measles in HCPs 
has been estimated as 13× higher 
than that for the general population 
(5) and is also higher among students 
(6). Vaccination against measles is 
recommended, not mandatory, for 
HCPs and health care students (HCSs) 
(medicine, nursing, and midwifery) 
who have no history of measles. The 
objective is to prevent transmission 
to a nonimmunized patient or another 
HCP, and from patients to susceptible 
HCPs. HCSs are in close and repeated 
contact with patients and therefore 
targeted by the recommendations. We 
conducted a cross-sectional survey 
in the university hospitals in Paris, 
France, to assess measles vaccination 
coverage in HCSs.
The sampling frame included 15 
hospitals with an obstetrics department. 
All midwifery students were selected. 
Other students were selected through 
a multistage random sampling. 
Sampling units were selected at each 
stage by simple random sampling. 
We selected 10 hospitals at the fi rst 
stage, 10 clinical wards by hospital 
at the second stage, and all nursing 
students and half the medical students 
by ward at the third stage. A total of 
116 students were required from each 
profession to estimate 50% coverage 
with 10% precision.
Students gave oral informed 
consent. Information was collected by 
face-to-face interview. Vaccination-
status was assessed from a document 
when available. Measles vaccination 
coverage was defi ned as the number 
of students with no history of measles 
who had received >1 dose of vaccine 
divided by the total number of students 
with no history of measles. The study 
was approved by the French Ethics 
Board and conducted from March 
2009 through July 2009.
Of the 106 selected wards, 10 
could not be included (clearance 
from the head of department was 
not given). Of the 488 selected 
students, 432 were enrolled in the 
study (participation rate 88.5%); 
178 (41%) were medical students, 
147 (34%) nursing students, and 
107 (25%) midwifery students. A 
document confi rming the student’s 
vaccination status was available for 
376 (87%) students; 38 (10.1%) had 
a history of measles (removed from 
analysis). Median age was 22 years 
(interquartile range 21–24 years); 74% 
were female. Measles vaccination 
was cited by 61.5% (95% confi dence 
interval [CI] 50.0%–71.9%) as a 
recommended vaccination. Measles 
vaccination coverage was 79.3% 
(95% CI 71.0%–75.8%) for >1 dose 
and 49.6% (95% CI 40.3%–59.1%) 
for 2 doses (Table). When considering 
only the students’ accounts (without 
written confi rmation), 1- and 2-dose 
vaccination coverage was 93.3% 
(95% CI 88.0%–96.3%) and 83.6% 
(95% CI 68.0%–92.4%), respectively. 
In multivariate analysis, younger 
students (<22 years of age) were 
more likely to have had 1 dose than 
older students (p<0.001).
In the context of measles 
epidemics affecting France, and 
considering that the World Health 
Organization recommends 95% 
coverage of the population with 2 
doses of a measles vaccine, our study 
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Table. Age, gender ratio, and rates of measles vaccination coverage for health care students, Paris, France* 
Characteristic Medical students, n = 178 Nursing students, n = 147 Midwifery students, n = 107 Total, n = 432 
Median age, y 23 22 22 22
Gender ratio, M:F 0.68 0.09 0.05 0.26
One dose, % (95% CI) 79.9 (67.1–88.6) 85.7 (67.1–88.6) 76.8 (63.1–86.5) 79.3 (71.0–85.8) 
Two doses, % (95% CI) 46.3 (31.2–62.2) 66.9 (55.2–76.8) 55.7 (41.1–69.4) 49.6 (40.3–59.1) 
*CI, confidence interval. 
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shows insuffi cient coverage among 
students currently being trained as 
HCPs in university hospitals within 
the Paris area. Thus, all unvaccinated 
students (20.7%) and ≈5% of the 50% 
who have received 1 dose could be 
susceptible to measles. Moreover, 
a rather low proportion of students 
knew that measles vaccination was 
recommended, as described for HCPs 
(7), which may explain the insuffi cient 
coverage.
In France, this situation has 
resulted in several measles outbreaks 
within hospitals in recent years (8). 
Particular efforts should be made 
in certain units, such as pediatrics, 
because an early waning of maternal 
antibodies has been demonstrated (9). 
Measures should be taken to reinforce 
the vaccination policy in this well-
defi ned group; information can be 
obtained and follow-up vaccinations 
can be provided easily during their 
training period. A mandatory health 
check could contribute to increasing 
the vaccination coverage (10).
Our study provides original 
data for measles vaccination 
coverage in HCSs in France. A 
similar conclusion applies to HCS-
recommended vaccines for which we 
found insuffi cient coverage (<50% 
had received a pertussis booster 
in the past 15 years and only 6/27 
without a history of varicella have 
been vaccinated against varicella). 
Such evaluations should be performed 
regularly. Although our data were 
collected from a representative sample 
of students in Paris, it is likely that 
the situation is qualitatively similar 
in other regions and therefore could 
contribute to future nosocomial 
epidemics. Mandatory vaccination 
of HCPs against vaccine-preventable 
diseases protects not only the HCP 
and his/her family, but also protects 
the patient. Increased vaccination 
of this group should contribute to a 
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ulcerans in Woman 
and Cat
To the Editor: Diphtheria and 
diphtheria-like illness are caused by 
Corynebacterium spp. that harbor 
the diphtheria toxin–encoding tox 
gene. Recently in many industrialized 
countries, cases of diphtheria-like 
infection caused by toxigenic C. 
ulcerans have outnumbered those 
caused by toxigenic C. diphtheriae 
(1,2). C. ulcerans infection was 
originally associated with consumption 
of raw milk and dairy products or 
contact with cattle, but C. ulcerans 
has increasingly been isolated from 
domestic animals such as pet dogs 
and cats (3–5). So far, isolation of an 
identical toxigenic C. ulcerans strain 
from an animal and its owner has been 
documented only for dogs (3,4) and 
a pig (6). We report the isolation of 
an identical toxigenic C. ulcerans 
strain from an asymptomtic pet 
cat and a person with pharyngeal 
diphtheria-like illness; therefore, it 
might be speculated that the woman 
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